title: Hormonal supplementation as treatment for cyclical rashes in patients with systemic lupus erythematosus.
abstract: Skin involvement is common in patients with SLE, and in some cases is related to the menstrual period. We describe the clinical course of 3 patients with menstrual related rashes who experienced a significant improvement from their skin disease after the initiation of oral contraceptives. The potential role of hormones in the manifestations of SLE is discussed.
authors.affiliation: National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Pando
authors.forename: M F
authors.initials: MF
authors.lastname: Gourley
authors.forename: R L
authors.initials: RL
authors.lastname: Wilder
authors.forename: L J
authors.initials: LJ
authors.lastname: Crofford
mesh_terms: D000293:Adolescent; D002648:Child; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D003872:Dermatitis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D004338:Drug Combinations; D045166:Estradiol Congeners / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000503:physiopathology; D008597:Menstrual Cycle; D009644:Norgestrel / Q000627:therapeutic use
chemical_list: D003276:Contraceptives, Oral; D004338:Drug Combinations; D045166:Estradiol Congeners; D009644:Norgestrel; D004997:Ethinyl Estradiol